AVENUE SOLUTIONS

AVENUE SOLUTIONS filed a Q2 report for TAKEDA PHARMACEUTICALS AMERICA, INC. on July 20, 2026, reporting $20,000 in lobbying income.

Lobbying for TAKEDA PHARMACEUTICALS AMERICA, INC. · Pharmaceutical company

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Lobbying activity 1

Issues related to drug pricing and reimbursement for prescription drugs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.